Phase II Clinical Development of New Drugs
Av Ding-Geng Chen, Shuyen Ho, Naitee Ting, Joseph C. Cappelleri, 2018.Del av serien ICSA Book Series in Statistics.
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
Språk: Engelsk
Oppdag mer
Phase II Clinical Development of New Drugs
Av Ding-Geng Chen, Shuyen Ho, Naitee Ting, Joseph C. Cappelleri, 2018.Del av serien ICSA Book Series in Statistics.
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
Oppdag mer
Språk: Engelsk
Ved å fullføre kjøpet aksepterer du kjøpsvilkårene.
